Get started
Author

Carlo Tumscitz

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
2018 · Pascal Vranckx, Marco Valgimigli, et al. · The Lancet · 823
PDF
Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
2012 · Marco Valgimigli, Gianluca Campo, et al. · Circulation · 674
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction
2023 · Simone Biscaglia, Vincenzo Guiducci, et al. · New England Journal of Medicine · 319
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
2019 · Anna Franzone, Eugène McFadden, et al. · Journal of the American College of Cardiology · 156
Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention
2013 · Marco Valgimigli, Matteo Tebaldi, et al. · JACC: Cardiovascular Interventions · 139
PDF
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial
2019 · Patrick W Serruys, Kuniaki Takahashi, et al. · European Heart Journal · 128
PDF
Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis
2013 · Gianluca Campo, Matteo Tebaldi, et al. · Journal of the American College of Cardiology · 70
PDF
Angio-Based Index of Microcirculatory Resistance for the Assessment of the Coronary Resistance: A Proof of Concept Study
2020 · Matteo Tebaldi, Simone Biscaglia, et al. · Journal of Interventional Cardiology · 66
PDF
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention
2010 · Marco Valgimigli, Gianluca Campo, et al. · American Heart Journal · 64
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management
2018 · Giuseppe Gargiulo, Sara Ariotti, et al. · JACC: Cardiovascular Interventions · 63
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY
2020 · Felice Gragnano, Dik Heg, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 62
PDF
Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention
2017 · Raffaele Piccolo, Giuseppe Gargiulo, et al. · Annals of Internal Medicine · 60
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI
2023 · Simone Biscaglia, Filippo Maria Verardi, et al. · JACC: Cardiovascular Interventions · 59
Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter I talian Registry (the FREAK Study)
2015 · Matteo Tebaldi, Simone Biscaglia, et al. · Catheterization and Cardiovascular Interventions · 54
Acute myocardial infarction and large coronary thrombosis in a patient with COVID‐19
2020 · Delio Tedeschi, Andrea Rizzi, et al. · Catheterization and Cardiovascular Interventions · 49
PDF
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI
2021 · Marco Valgimigli, Roxana Mehran, et al. · JACC: Cardiovascular Interventions · 43
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis
2017 · Rita Pavasini, Sara Ruggerini, et al. · European Heart Journal - Cardiovascular Imaging · 43
PDF
Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no‐reflow during primary PCI: The RESTORE observational study
2020 · Eliano P. Navarese, Lara Frediani, et al. · Catheterization and Cardiovascular Interventions · 41
Radial Artery Access for Percutaneous Cardiovascular Interventions: Contemporary Insights and Novel Approaches
2019 · Renato Francesco Maria Scalise, Armando Mariano Salito, et al. · Journal of Clinical Medicine · 41
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry
2016 · Simone Biscaglia, Gianluca Campo, et al. · Platelets · 37
Coronary Physiology Guidance vs Conventional Angiography for Optimization of Percutaneous Coronary Intervention
2023 · Simone Biscaglia, Filippo Maria Verardi, et al. · JACC: Cardiovascular Interventions · 27
Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper
2022 · L. Golino, G. Caiazzo, et al. · International Journal of Cardiology · 27
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
2019 · Ply Chichareon, Yoshinobu Onuma, et al. · EuroIntervention · 26
Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design
2008 · Marco Valgimigli, Gianluca Campo, et al. · Cardiovascular Drugs and Therapy · 26
Acute myocardial infarction caused by amphetamines: a case report and review of the literature.
2001 · G M Costa, C Pizzi, et al. · PubMed · 26
Works count: 81
Citation count: 3,494
H-index: 25
I10-index: 43
Year
Topic
Type